- EG-018
- NA-PCZMO
Ujváry, I. The bumpy road ahead for forensic scientists. Synthetic cannabinoids to (unwel)come Spice II Plus, 5 Jun 2014. 405 kB. #EG-018
Liu, C; Jia, W; Hua, Z; Qian, Z. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F–NPB-22-7N, 5F–AKB-48-7N, 5F–EDMB-PINACA, EMB-FUBINACA, and EG-018 Drug Test. Anal., 1 Aug 2017, 9 (8), 1251–1261. 1.8 MB. https://doi.org/10.1002/dta.2160 #6 LC,MS,NMR
Angerer, V; Mogler, L; Steitz, J; Bisel, P; Hess, C; Schoeder, CT; Müller, CE; Huppertz, LM; Westphal, F; Schäper, J; Auwärter, V. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE Drug Test. Anal., 1 Mar 2018, 10 (3), 597-603. 511 kB. https://doi.org/10.1002/dta.2237 MS,NMR,IR
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Hess, C; Murach, J; Krueger, L; Scharrenbroch, L; Unger, M; Madea, B; Sydow, K. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples Drug Test. Anal., 1 May 2017, 9 (5), 721-733. 267 kB. https://doi.org/10.1002/dta.2030 #EG-018 LC,MS
Mogler, L; Franz, F; Wilde, M; Huppertz, LM; Halter, S; Angerer, V; Moosmann, B; Auwärter, V. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples Drug Test. Anal., 1 Sep 2018, 10 (9), 1417–1429. 2.0 MB. https://doi.org/10.1002/dta.2398 #EG-018 LC,MS
Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonist new psychoactive substances: Evolution In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 191-226. 1.2 MB. https://doi.org/10.1007/164_2018_144 #102
Anon. Ordinance amending the Annex to the New Psychoactive Substances Act [Neue-psychoaktive-Stoffe-Gesetz] as well as Annexes to the Narcotics Act [Betäubungsmittelgesetz] 14 Mar 2019. 704 kB. #EG-018
Wouters, E; Walraed, J; Robertson, MJ; Meyrath, M; Szpakowska, M; Chevigné, A; Skiniotis, G; Stove, C. Assessment of biased agonism among distinct synthetic cannabinoid receptor agonist scaffolds ACS Pharmacol. Transl. Sci., 10 Apr 2020, 3 (2), 285–295. 2.0 MB. https://doi.org/10.1021/acsptsci.9b00069 #18
Alam, RM; Keating, JJ. Adding more “spice” to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists Drug Test. Anal., 1 Mar 2020, 12 (3), 297–315. 2.8 MB. https://doi.org/10.1002/dta.2752 #85 Structure 71 has a single bond where a double bond belongs
Andrews, R; Jorge, R; Christie, R; Gallegos, A. From JWH‐018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present day Drug Test. Anal., 1 Apr 2023, 15 (4), 378–387. 1.2 MB. https://doi.org/10.1002/dta.3422 #EG-018